Guillain-Barre syndrome: background incidence rates in The Netherlands

被引:14
|
作者
van der Maas, Nicoline A. T. [1 ,2 ,3 ]
Kramer, Merlijn A. [1 ]
Jacobs, Bart C. [2 ,3 ]
van Soest, Eva M. [4 ]
Dieleman, Jeanne P. [4 ]
Kemmeren, Jeanet M. [1 ]
de Melker, Hester E. [1 ]
Sturkenboom, Miriam C. J. M. [5 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands
[2] Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands
[3] Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands
[4] Univ Med Ctr, Dept Med Informat, Rotterdam, Netherlands
[5] Univ Med Ctr, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
关键词
Guillain-Barre syndrome; incidence rate; vaccination; PATIENT RECORDS; IMMUNIZATION; SURVEILLANCE; FEATURES;
D O I
10.1111/j.1529-8027.2011.00356.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Guillain-Barre syndrome (GBS) is a (sub) acute polyradiculoneuropathy, which may occur following immunization. To interpret the occurrence of GBS after introduction of large-scale immunization programmes, it is important to define recent background incidence rates (IRs) of GBS. We used a general practitioner electronic medical record database to assess age-specific GBS IRs between 1996 and 2008 in The Netherlands. All possible GBS cases were manually reviewed. Validated incident cases were reviewed by a neurologist (B. J.) for diagnostic certainty using the GBS case definition of the Brighton Collaboration (BC). In a population of 638,891 persons, we identified 23 validated incident GBS cases (mean age 46 years). IR was 1.14 per 100,000 person years (95% confidence interval [CI] 0.67-1.61) and was lower for people under 50 years (0.76; 95% CI 0.41-1.32) compared with elderly of 50 years or older (1.80; 95% CI 0.98-3.05). Only six cases fulfilled level 1 or 2 of diagnostic certainty of the BC case definition. IR of GBS increases with age. As vaccinations are often targeted at specific age groups, age-specific rates should be used to monitor GBS observed versus expected rates after introduction of large-scale vaccination programmes.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [21] Hypoalbuminemia in Guillain-Barre syndrome
    Jia, Linpei
    Zhang, Hongliang
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 77 : 249 - 250
  • [22] Guillain-Barre syndrome and cytomegalovirus
    Gault, Elyanne
    Orlikowski, David
    Gaillard, Jean-Louis
    Rozenberg, Flore
    Leruez-Ville, Marianne
    VIROLOGIE, 2011, 15 (05) : 319 - 325
  • [23] Asymmetric Guillain-Barre syndrome
    Logullo, F.
    Manicone, M.
    Di Bella, P.
    Provinciali, L.
    NEUROLOGICAL SCIENCES, 2006, 27 (05) : 355 - 359
  • [24] Tracheostomy in Guillain-Barre syndrome
    Lawn, ND
    Wijdicks, EFM
    MUSCLE & NERVE, 1999, 22 (08) : 1058 - 1062
  • [25] Vaccines and Guillain-Barre Syndrome
    Haber, Penina
    Sejvar, James
    Mikaeloff, Yann
    DeStefan, Frank
    DRUG SAFETY, 2009, 32 (04) : 309 - 323
  • [26] Hyperreflexic Guillain-Barre syndrome
    Baheti, Neeraj N.
    Manuel, Davis
    Shinde, Pranav D.
    Radhakrishnan, Ashalatha
    Nair, Muraleedharan
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2010, 13 (04) : 305 - 306
  • [27] Plasmapheresis in Guillain-Barre syndrome
    Korczyn, AD
    Nisipeanu, P
    EUROPEAN JOURNAL OF NEUROLOGY, 1996, 3 (05) : 417 - 423
  • [28] Hemiparetic Guillain-Barre syndrome
    Kim, Jee-Eun
    Yuki, Nobuhiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 361 : 131 - 132
  • [29] Guillain-Barre syndrome (GBS)
    Pithadia, Anand B.
    Kakadia, Nimisha
    PHARMACOLOGICAL REPORTS, 2010, 62 (02) : 220 - 232
  • [30] Guillain-Barre syndrome in pregnancy
    Hledikova, A.
    Hruban, L.
    Jura, R.
    Sas, I
    Hrdy, O.
    Janku, P.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2021, 86 (03): : 189 - 193